FRIDAY, April 28, 2017 -- Young adults with uncomplicated epilepsy who remain seizure-free do as well as siblings without the disorder in education, employment, driving and independent living, a new study says.
The 15-year study included 361 people in Connecticut with childhood-onset epilepsy and 173 of their brothers and sisters.
FRIDAY, June 9, 2017 -- A host of new drugs that appear to prevent migraine headaches are in the final stages of testing and approval in the United States.
"What's really exciting about this is that until this development, we have not had a migraine-specific preventive at all," said Dr. Peter Goadsby, a professor of neurology at the University of California, San Francisco.
MONDAY, May 8, 2017 -- The first new drug to treat amyotrophic lateral sclerosis (ALS) in more than 20 years has been approved by the U.S. Food and Drug Administration.
Radicava (edaravone) is taken intravenously daily for 14 days, followed by 14 days without the drug. Subsequent treatment cycles consist of treatment for 10 out of 14 days, followed by 14 days without the drug.
WEDNESDAY, April 19, 2017 -- Adjusting the so-called body clock might help severely brain-injured patients regain consciousness from a coma, researchers say.
The preliminary study included 18 people with severe brain injuries. Their body temperature was continually monitored for one week, which enabled researchers to calculate the length of each patient's circadian rhythm -- the natural cycles that tell you when to sleep, wake or eat.